Cargando…
Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol
INTRODUCTION: The adoption of business process model notation (BPMN) in modelling healthcare trajectory can enhance the efficiency and efficacy of healthcare organisations, improve patient outcomes while restraining costs. Existing systematic reviews have been inconclusive regarding the effectivenes...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152926/ https://www.ncbi.nlm.nih.gov/pubmed/35636803 http://dx.doi.org/10.1136/bmjopen-2021-060357 |
_version_ | 1784717742922792960 |
---|---|
author | Kassim, Said Abasse Gartner, Jean-Baptiste Labbé, Laurence Landa, Paolo Paquet, Catherine Bergeron, Frédéric Lemaire, Célia Côté, André |
author_facet | Kassim, Said Abasse Gartner, Jean-Baptiste Labbé, Laurence Landa, Paolo Paquet, Catherine Bergeron, Frédéric Lemaire, Célia Côté, André |
author_sort | Kassim, Said Abasse |
collection | PubMed |
description | INTRODUCTION: The adoption of business process model notation (BPMN) in modelling healthcare trajectory can enhance the efficiency and efficacy of healthcare organisations, improve patient outcomes while restraining costs. Existing systematic reviews have been inconclusive regarding the effectiveness of BPMN in modelling healthcare trajectory. The aims of this scoping review are to map and aggregate existing evidence on the benefits and limitations associated with BPMN in healthcare trajectory, highlighting areas of improvement on BPMN and its extensions in healthcare. We will assess BPMN’s ability to model key dimensions or concepts of the healthcare process and to meet the needs of stakeholders. The review will highlight the advantages of this approach to support clinical activities and decision-making processes associated with the healthcare trajectory, proposing a conceptual framework for improving the use of BPMN in healthcare. METHODS AND ANALYSIS: This study will be performed in accordance with the methodological framework suggested by Arksey and O’Malley. A wide range of electronic databases and grey literature sources will be systematically searched using predefined keywords. The review will include any study design focusing on the application of the BPMN approach for optimising healthcare trajectories, published in either English or French from 1 January 2004 to 9 December 2021. Two reviewers will independently screen titles, abstracts and full-text articles and select articles meeting the inclusion criteria. A customised data extraction form will be used to extract data. The results will be presented using descriptive statistics and thematic analysis on qualitative data. ETHICS AND DISSEMINATION: Research ethics approval is not required. Review findings will be used to advance understanding about BPMN, its extensions and application in healthcare trajectory optimisation. The review will develop recommendations on tailoring BPMN strategies for optimising care pathways and decision-making processes. Findings will be disseminated in peer-reviewed journals, conferences and discussions with relevant organisations and stakeholders. |
format | Online Article Text |
id | pubmed-9152926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-91529262022-06-16 Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol Kassim, Said Abasse Gartner, Jean-Baptiste Labbé, Laurence Landa, Paolo Paquet, Catherine Bergeron, Frédéric Lemaire, Célia Côté, André BMJ Open Health Informatics INTRODUCTION: The adoption of business process model notation (BPMN) in modelling healthcare trajectory can enhance the efficiency and efficacy of healthcare organisations, improve patient outcomes while restraining costs. Existing systematic reviews have been inconclusive regarding the effectiveness of BPMN in modelling healthcare trajectory. The aims of this scoping review are to map and aggregate existing evidence on the benefits and limitations associated with BPMN in healthcare trajectory, highlighting areas of improvement on BPMN and its extensions in healthcare. We will assess BPMN’s ability to model key dimensions or concepts of the healthcare process and to meet the needs of stakeholders. The review will highlight the advantages of this approach to support clinical activities and decision-making processes associated with the healthcare trajectory, proposing a conceptual framework for improving the use of BPMN in healthcare. METHODS AND ANALYSIS: This study will be performed in accordance with the methodological framework suggested by Arksey and O’Malley. A wide range of electronic databases and grey literature sources will be systematically searched using predefined keywords. The review will include any study design focusing on the application of the BPMN approach for optimising healthcare trajectories, published in either English or French from 1 January 2004 to 9 December 2021. Two reviewers will independently screen titles, abstracts and full-text articles and select articles meeting the inclusion criteria. A customised data extraction form will be used to extract data. The results will be presented using descriptive statistics and thematic analysis on qualitative data. ETHICS AND DISSEMINATION: Research ethics approval is not required. Review findings will be used to advance understanding about BPMN, its extensions and application in healthcare trajectory optimisation. The review will develop recommendations on tailoring BPMN strategies for optimising care pathways and decision-making processes. Findings will be disseminated in peer-reviewed journals, conferences and discussions with relevant organisations and stakeholders. BMJ Publishing Group 2022-05-27 /pmc/articles/PMC9152926/ /pubmed/35636803 http://dx.doi.org/10.1136/bmjopen-2021-060357 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Health Informatics Kassim, Said Abasse Gartner, Jean-Baptiste Labbé, Laurence Landa, Paolo Paquet, Catherine Bergeron, Frédéric Lemaire, Célia Côté, André Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol |
title | Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol |
title_full | Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol |
title_fullStr | Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol |
title_full_unstemmed | Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol |
title_short | Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol |
title_sort | benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol |
topic | Health Informatics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152926/ https://www.ncbi.nlm.nih.gov/pubmed/35636803 http://dx.doi.org/10.1136/bmjopen-2021-060357 |
work_keys_str_mv | AT kassimsaidabasse benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol AT gartnerjeanbaptiste benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol AT labbelaurence benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol AT landapaolo benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol AT paquetcatherine benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol AT bergeronfrederic benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol AT lemairecelia benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol AT coteandre benefitsandlimitationsofbusinessprocessmodelnotationinmodellingpatienthealthcaretrajectoryascopingreviewprotocol |